Literature DB >> 3791404

Papaverine: the ideal coronary vasodilator for investigating coronary flow reserve? A study of timing, magnitude, reproducibility, and safety of the coronary hyperemic response after intracoronary papaverine.

F Zijlstra, P W Serruys, P G Hugenholtz.   

Abstract

A potent, short-acting vasodilator that induces a maximal hyperemic response of the coronary vascular bed is needed to determine coronary flow reserve. In 12 patients, we measured coronary sinus blood flow by thermodilution over a period of 2 min during which a bolus of 10 mg papaverine was given into the left main coronary artery. This was repeated after 5 min to assess the reproducibility of the changes. The maximal hyperemic response lasted from 24 until 37 sec after papaverine administration. There was no significant difference between the two consecutive hyperemic responses (Student's t-test for paired observations). The mean difference between first and second hyperemic responses at 30 sec was 7.0% (SD +/- 6.2%). In conclusion, 10 mg of intracoronary papaverine is a short-lasting and reproducible means of inducing a maximal hyperemic response in the coronary vascular bed and therefore appears to be the ideal agent for investigating coronary flow reserve.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791404     DOI: 10.1002/ccd.1810120505

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  12 in total

1.  Mean transit time for videodensitometric assessment of myocardial perfusion and the concept of maximal flow ratio: a validation study in the intact dog and a pilot study in man.

Authors:  N H Pijls; G J Uijen; A Hoevelaken; T Pijnenburg; K L van Leeuwen; J H Fast; H S Bos; W R Aengevaeren; T van der Werf
Journal:  Int J Card Imaging       Date:  1990

2.  Intracoronary papaverine and complete atrioventricular block.

Authors:  D A Chauhan; P A Mullins; S T Thuraisingham; P M Schofield
Journal:  BMJ       Date:  1992-10-10

Review 3.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

4.  Endothelial control of lower limb blood flow in chronic heart failure.

Authors:  D C Lindsay; D R Holdright; D Clarke; I S Anand; P A Poole-Wilson; P Collins
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

5.  Correlations between quantitative cineangiography, coronary flow reserve measured with digital subtraction cineangiography and exercise thallium perfusion scintigraphy.

Authors:  F Zijlstra; P Fioretti; J H Reiber; P W Serruys
Journal:  Int J Card Imaging       Date:  1988

Review 6.  [Methods for coronary functional assessment].

Authors:  M Elsner
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

7.  Three-dimensional reconstruction of myocardial contrast perfusion from biplane cineangiograms by means of linear programming techniques.

Authors:  A C Dumay; H Minderhoud; J J Gerbrands; F Zijlstra; C E Essed; P W Serruys; J H Reiber
Journal:  Int J Card Imaging       Date:  1988

8.  Coronary flow reserve in patients with chest pain and normal coronary arteries.

Authors:  D R Holdright; D C Lindsay; D Clarke; K Fox; P A Poole-Wilson; P Collins
Journal:  Br Heart J       Date:  1993-12

9.  Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction.

Authors:  Rahn Ilsar; Chirapan Chawantanpipat; Kim H Chan; Timothy A Dobbins; Richard Waugh; Annemarie Hennessy; David S Celermajer; Martin K C Ng
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

10.  Percutaneous coronary rotational angioplasty: preliminary clinical and quantitative imaging results.

Authors:  G J Laarman; P W Serruys
Journal:  Int J Card Imaging       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.